Es gab 50 kürzliche Insider-Transaktionen für Oncotelic Therapeutics, Inc. (OTLC), darunter 38 Käufe und 10 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $948.56K und die gesamten Insider-Verkäufe auf RSU Award.
Bedeutende Insider mit kürzlicher Aktivität umfassen Trieu Vuong, King Steven W, Maida Anthony E Iii. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — OTLC
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2025-01-31 |
Trieu Vuong |
10 Percent Owner, Officer: Chairman and CEO |
Informierter Kauf |
63,775 |
$0.03 |
$1.79K |
93,189,560 |
| 2025-01-30 |
Trieu Vuong |
10 Percent Owner, Officer: Chairman and CEO |
Informierter Kauf |
100,003 |
$0.03 |
$2.8K |
93,125,785 |
| 2025-01-29 |
Trieu Vuong |
10 Percent Owner, Officer: Chairman and CEO |
Informierter Kauf |
183,066 |
$0.03 |
$5.13K |
93,025,782 |
| 2024-11-22 |
Trieu Vuong |
10 Percent Owner, Officer: Chairman and CEO |
Informierter Kauf |
298,499 |
$0.03 |
$8.63K |
92,842,716 |
| 2024-08-23 |
Trieu Vuong |
10 Percent Owner, Officer: Chairman and CEO |
Informierter Kauf |
500,000 |
$0.02 |
$10K |
92,544,217 |
| 2023-06-29 |
Trieu Vuong |
10 Percent Owner, Officer: Chairman and CEO |
Informierter Kauf |
425,000 |
$0.02 |
$8.93K |
92,044,217 |
| 2023-06-28 |
Trieu Vuong |
10 Percent Owner, Officer: Chairman and CEO |
Informierter Kauf |
75,000 |
$0.03 |
$1.95K |
91,619,217 |
| 2023-06-16 |
Trieu Vuong |
10 Percent Owner, Officer: Chairman and CEO |
Informierter Kauf |
100,000 |
$0.03 |
$2.6K |
91,544,217 |
| 2023-06-14 |
Trieu Vuong |
10 Percent Owner, Officer: Chairman and CEO |
Informierter Kauf |
400,000 |
$0.03 |
$13.04K |
91,444,217 |
| 2023-05-26 |
Trieu Vuong |
10 Percent Owner, Officer: Chairman and CEO |
Informierter Kauf |
126,888 |
$0.03 |
$4.33K |
91,044,217 |
| 2023-05-02 |
Trieu Vuong |
10 Percent Owner, Officer: Chairman and CEO |
Informierter Kauf |
100,000 |
$0.05 |
$4.5K |
90,917,329 |
| 2022-12-06 |
Trieu Vuong |
Chairman and CEO |
Informierter Kauf |
120,000 |
$0.05 |
$6K |
90,558,021 |
| 2022-11-22 |
Trieu Vuong |
Chairman and CEO |
Informierter Kauf |
70,000 |
$0.08 |
$5.6K |
90,438,021 |
| 2022-09-26 |
Trieu Vuong |
10 Percent Owner, Officer: Chairman and CEO |
Informierter Kauf |
20,000 |
$0.07 |
$1.36K |
90,368,021 |
| 2022-08-25 |
Trieu Vuong |
Chairman and CEO |
Informierter Kauf |
80,000 |
$0.08 |
$6.56K |
90,348,021 |
| 2021-09-03 |
King Steven W |
Director |
RSU-Zuteilung |
500,000 |
$0.14 |
$69.65K |
500,000 |
| 2021-09-03 |
Maida Anthony E Iii |
Chief Clin. Ops. Officer |
RSU-Zuteilung |
600,000 |
$0.14 |
$83.58K |
600,000 |
| 2021-09-03 |
Trieu Vuong |
Chief Executive Officer |
RSU-Zuteilung |
225,000 |
- |
- |
225,000 |
| 2021-09-03 |
Saund Saran |
Chief Business Officer |
RSU-Zuteilung |
675,000 |
$0.14 |
$94.03K |
675,000 |
| 2021-07-08 |
King Steven W |
Director |
RSU-Zuteilung |
357,412 |
$0.16 |
$58.12K |
357,412 |
| 2021-07-08 |
Maida Anthony E Iii |
Chief Clinical Officer |
RSU-Zuteilung |
400,000 |
$0.16 |
$65.04K |
400,000 |
| 2021-07-08 |
Trieu Vuong |
10 Percent Owner, Officer: Chairman and CEO |
RSU-Zuteilung |
513,953 |
$0.16 |
$83.57K |
513,953 |
| 2021-07-08 |
Shah Amit B. |
Chief Financial Officer |
RSU-Zuteilung |
298,837 |
- |
- |
358,837 |
| 2021-07-08 |
Diamond David |
Director |
RSU-Zuteilung |
451,467 |
$0.16 |
$73.41K |
451,467 |
| 2021-07-08 |
Saund Saran |
Chief Business Officer |
RSU-Zuteilung |
216,279 |
$0.16 |
$35.17K |
216,279 |
| 2021-03-31 |
King Steven W |
Director |
Umwandlung (Verkauf) |
3,292 |
- |
- |
- |
| 2021-03-31 |
Maida Anthony E Iii |
Chief Clinical Officer |
Umwandlung (Verkauf) |
938 |
- |
- |
- |
| 2021-03-31 |
Trieu Vuong |
10 Percent Owner, Officer: Chairman and CEO |
Umwandlung (Verkauf) |
5,672 |
- |
- |
- |
| 2021-03-31 |
Saund Saran |
Chief Business Officer |
Umwandlung (Verkauf) |
16,355 |
- |
- |
- |
| 2020-11-24 |
Shah Amit B. |
Chief Financial Officer |
Informierter Kauf |
8,220 |
$0.19 |
$1.56K |
60,000 |
| 2020-11-23 |
Shah Amit B. |
Chief Financial Officer |
Informierter Kauf |
20,088 |
$0.19 |
$3.82K |
51,780 |
| 2020-11-20 |
Shah Amit B. |
Chief Financial Officer |
Informierter Kauf |
31,692 |
$0.20 |
$6.18K |
31,692 |
| 2020-11-19 |
Trieu Vuong |
Chief Executive Officer |
Informierter Kauf |
50,500 |
$0.19 |
$9.6K |
15,812,308 |
| 2020-11-19 |
Park Chulho |
Chief Technology Officer |
Informierter Kauf |
22,173 |
$0.18 |
$4.1K |
2,833,992 |
| 2020-05-11 |
King Steven W |
Director |
Veräußerung |
3,921,720 |
- |
- |
- |
| 2020-05-11 |
Maida Anthony E Iii |
Director |
Veräußerung |
938,646 |
- |
- |
- |
| 2020-03-26 |
Trieu Vuong |
Chief Executive Officer |
Informierter Kauf |
3,000 |
$0.12 |
$360.00 |
15,761,808 |
| 2020-01-22 |
Diamond David |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2019-04-22 |
Trieu Vuong |
10 Percent Owner, Officer: CEO and Chairman of the Board |
Unbekannt |
5,672,025 |
- |
- |
- |
| 2019-04-22 |
Hwang Larn |
10 Percent Owner |
Veräußerung |
19,350,411 |
- |
- |
- |
| 2019-04-22 |
Hsiao Chao |
10 Percent Owner |
Veräußerung |
14,070,529 |
- |
- |
- |
| 2019-04-22 |
Uckun Fatih |
10 Percent Owner, Officer: Chief Medical Officer |
Veräußerung |
7,052,762 |
- |
- |
- |
| 2019-04-22 |
Park Chulho |
10 Percent Owner, Officer: Chief Technical Officer |
Veräußerung |
13,285,013 |
- |
- |
- |
| 2018-06-20 |
Sandage Bobby W. Jr., Phd. |
Director |
RSU-Zuteilung |
258,171 |
$0.22 |
$56.8K |
258,171 |
| 2018-06-20 |
Chaplin David |
Director |
RSU-Zuteilung |
258,171 |
$0.22 |
$56.8K |
258,171 |
| 2018-06-20 |
Loar Matthew M |
Chief Financial Officer |
RSU-Zuteilung |
250,000 |
- |
- |
250,000 |
| 2018-06-20 |
Pedder Simon |
Director |
RSU-Zuteilung |
258,171 |
$0.22 |
$56.8K |
258,171 |
| 2018-06-20 |
Schwieterman William D |
President and CEO |
RSU-Zuteilung |
500,000 |
- |
- |
500,000 |
| 2018-06-20 |
Reynolds Donald Rogers |
Director |
RSU-Zuteilung |
258,171 |
$0.22 |
$56.8K |
258,171 |
| 2018-04-12 |
Loar Matthew M |
Chief Financial Officer |
Informierter Kauf |
125,000 |
$0.40 |
$50K |
125,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
